Tenapanor for constipation-predominant irritable bowel syndrome.
This article will elaborate on the clinical development program for tenapanor for this indication.
PMID: 32282867 [PubMed - as supplied by publisher]
Source: Drugs of Today - Category: Drugs & Pharmacology Tags: Drugs Today (Barc) Source Type: research
More News: Constipation | Diets | Drugs & Pharmacology | Food and Drug Administration (FDA) | Gastroenterology | Irritable Bowel Syndrome | Nutrition | Pain | Sodium